These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dramatic reduction of ventricular tachycardia burden after dronedarone plus mexiletine treatment in a patient refractory to hybrid ablation. Frutos-López M; Pedrote A; Acosta-Martínez J; Arana-Rueda E Rev Port Cardiol (Engl Ed); 2020 Mar; 39(3):171-173. PubMed ID: 32336522 [TBL] [Abstract][Full Text] [Related]
4. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia. Jung W; Mletzko R; Manz M; Nitsch J; Lüderitz B Pacing Clin Electrophysiol; 1993 Apr; 16(4 Pt 1):778-88. PubMed ID: 7683805 [TBL] [Abstract][Full Text] [Related]
6. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. AbdelWahab A; Sapp J Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent. Singh BN Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328 [TBL] [Abstract][Full Text] [Related]
8. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia]. Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771 [TBL] [Abstract][Full Text] [Related]
9. Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing. Naitoh N; Washizuka T; Takahashi K; Aizawa Y Jpn Circ J; 1998 Apr; 62(4):267-73. PubMed ID: 9583460 [TBL] [Abstract][Full Text] [Related]
10. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring]. Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of amiodarone-induced hyperthyroidism by carbimazole with maintenance of amiodarone]. Talard P; Bonal J; Cellarier G; Bouchiat C; Dussarat GV Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1301-3. PubMed ID: 8952829 [TBL] [Abstract][Full Text] [Related]
13. A patient with sustained ventricular tachycardia: identification of a responder to amiodarone using signal-averaged electrocardiogram. Kobayashi A; Nomura M; Sawa Y; Kawaguchi T; Koshiba K; Yamaguchi K; Kawano T; Wakatsuki T; Tabata T; Nisikado A; Ito S; Nakaya Y J Med Invest; 2004 Aug; 51(3-4):247-53. PubMed ID: 15460915 [TBL] [Abstract][Full Text] [Related]
15. A case of amiodarone and neuromyopathy. Silva Oropeza E; Peralta Rosado HR; Valero Elizondo C; Sadowinski E; Magaña Serrano JA Rev Invest Clin; 1997; 49(2):135-9. PubMed ID: 9294958 [TBL] [Abstract][Full Text] [Related]
16. Hyperkalemia probably reverses the antiarrhythmic effects of amiodarone: a case report. Akiyama J; Tomizawa T; Umezawa S; Morishima A Jpn Circ J; 1999 Apr; 63(4):323-5. PubMed ID: 10475784 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation. Heger JJ; Prystowsky EN; Zipes DP Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835 [TBL] [Abstract][Full Text] [Related]
18. Therapy-resistant ventricular tachycardia caused by amiodarone-induced thyrotoxicosis: a case report of electrical storm. Erdogan HI; Gul EE; Gok H; Nikus KC Am J Emerg Med; 2012 Nov; 30(9):2092.e5-7. PubMed ID: 22386340 [TBL] [Abstract][Full Text] [Related]
19. Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator. Gao D; Van Herendael H; Alshengeiti L; Dorian P; Mangat I; Korley V; Ahmad K; Golovchiner G; Aves T; Pinter A J Cardiovasc Pharmacol; 2013 Aug; 62(2):199-204. PubMed ID: 23609328 [TBL] [Abstract][Full Text] [Related]
20. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia. Toivonen L; Kadish A; Morady F Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]